Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Trina Lum
Observed name:
T. Lum
Institutions:
Royal Prince Alfred Hospital,
NSW Health Pathology
Observed institutions:
The University of Sydney,
Garvan Institute of Medical Research,
Royal Prince Alfred Hospital,
Chris O’Brien Lifehouse,
Westmead Institute,
The Kinghorn Cancer Centre,
National Health and Medical Research Council,
NSW Health Pathology,
Western Sydney University
show all 9
ORCID:
0009-0009-2207-2834
Observed ORCID:
0009-0009-2207-2834
OpenAlex ID:
A5111835280
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
2020
·
Elizabeth C. Paver
, Wendy A. Cooper
, et al.
·
Pathology
·
244
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
2017
·
Steven C. Kao
, Yuen Yee Cheng
, et al.
·
Journal of Thoracic Oncology
·
149
Dynamics of Chemokine, Cytokine, and Growth Factor Serum Levels in BRAF-Mutant Melanoma Patients during BRAF Inhibitor Treatment
2014
·
James S Wilmott
, Lauren E Haydu
, et al.
·
The Journal of Immunology
·
79
Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
2013
·
Alexander M. Menzies
, Trina Lum
, et al.
·
The American Journal of Surgical Pathology
·
76
Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype
2016
·
Laveniya Satgunaseelan
, Ruta Gupta
, et al.
·
Pathology
·
71
Screening for ROS 1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target
2016
·
Christina I Selinger
, Bob T Li
, et al.
·
Histopathology
·
62
Diagnostic and prognostic utility of Mastermind-like 2 (MAML2) gene rearrangement detection by fluorescent in situ hybridization (FISH) in mucoepidermoid carcinoma of the salivary glands
2016
·
Peter P. Luk
, James Wykes
, et al.
·
Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
·
62
Oligoastrocytomas: throwing the baby out with the bathwater?
2014
·
Paul Wilcox
, Cheryl C. Y. Li
, et al.
·
Acta Neuropathologica
·
61
BRAF mutations in non-small cell lung cancer.
2015
·
Peter P Luk
, Bing Yu
, et al.
·
PubMed Central
·
52
Primary and Metastatic Cutaneous Melanomas Express ALK Through Alternative Transcriptional Initiation
2016
·
Klaus J. Busam
, Ricardo E. Vilain
, et al.
·
The American Journal of Surgical Pathology
·
49
PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma
2017
·
Edward Roper
, Trina Lum
, et al.
·
Pathology
·
48
LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma
2016
·
Amy D. Marshall
, Michelle van Geldermalsen
, et al.
·
International Journal of Cancer
·
47
PDF
Mammary analogue secretory carcinoma: an evaluation of its clinicopathological and genetic characteristics
2015
·
Peter P. Luk
, Christina I. Selinger
, et al.
·
Pathology
·
46
p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis
2017
·
Laveniya Satgunaseelan
, Noel Chia
, et al.
·
Pathology
·
36
BRAFV600E and NRASQ61L/Q61R mutation analysis in metastatic melanoma using immunohistochemistry: a study of 754 cases highlighting potential pitfalls and guidelines for interpretation and reporting
2016
·
Hojabr Kakavand
, Emily Walker
, et al.
·
Histopathology
·
35
p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma
2016
·
Laveniya Satgunaseelan
, Sohaib A. Virk
, et al.
·
Pathology
·
32
Real-world programmed death-ligand 1 prevalence rates in non-small cell lung cancer: correlation with clinicopathological features and tumour mutation status
2020
·
Mikaela Holmes
, Annabelle Mahar
, et al.
·
Journal of Clinical Pathology
·
20
Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas
2014
·
Hojabr Kakavand
, Oana Crainic
, et al.
·
Pathology
·
20
Telomerase expression as a predictive marker of radiotherapy response in rectal cancer: in vitro and in vivo study
2012
·
Joo-Shik Shin
, Terence Foot
, et al.
·
Pathology
·
19
Molecular assays in breast cancer pathology
2011
·
Sandra A. O’Toole
, Christina I. Selinger
, et al.
·
Pathology
·
17
Equivocal ALK fluorescence in‐situ hybridization ( FISH ) cases may benefit from ancillary ALK FISH probe testing
2015
·
Christina Selinger
, Wendy Cooper
, et al.
·
Histopathology
·
16
Human Hearts Intrinsically Increase Cardiomyocyte Mitosis After Myocardial Infarction
2025
·
Robert D. Hume
, Jessica Warwick
, et al.
·
Circulation Research
·
7
The role of p16 expression in oral squamous cell carcinoma
2015
·
Laveniya Satgunaseelan
, Sohaib Virk
, et al.
·
Pathology
·
3
BRAF (v600e) and NRAS (q61r/q61l) mutation analysis using immunohistochemistry: Implications for routine mutation testing of melanoma samples
2016
·
Hojabr Kakavand
, Trina Lum
, et al.
·
Pathology
·
2
PDF
Integration of Whole-Genome Sequencing Analysis with Unique Patient-Derived Models Reveals Clinically Relevant Drug Targets in TFCP2 Fusion–Defined Rhabdomyosarcoma
2025
·
Patrick Bergsma
, Sean Porazinski
, et al.
·
Molecular Cancer Therapeutics
·
1
Show more works
View as search
Works count:
53
Citation count:
1,257
H-index:
19
I10-index:
21
Year
Topic
Type